These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37240189)

  • 21. Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm?
    Dinur T; Bauer P; Beetz C; Kramp G; Cozma C; Iurașcu MI; Becker-Cohen M; Istaiti M; Rolfs A; Zimran A; Revel-Vilk S
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive and long-term outcomes of enzyme replacement therapy followed by stem cell transplantation in children with Gaucher disease type 1 and 3.
    Anurathapan U; Tim-Aroon T; Zhang W; Sanpote W; Wongrungsri S; Khunin N; Chutipongtanate S; Chirdkiatgumchai V; Ngiwsara L; Jaovisidha S; Khongkraparn A; Pakakasama S; Svasti J; Setchell KDR; Wattanasirichaigoon D; Hongeng S
    Pediatr Blood Cancer; 2023 Mar; 70(3):e30149. PubMed ID: 36562549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical-genetic characteristics and treatment outcomes of Turkish children with Gaucher disease type 1 and type 3: A sixteen year single-center experience.
    Gumus E; Karhan AN; Hizarcioglu-Gulsen H; Demir H; Ozen H; Saltik Temizel IN; Dokmeci Emre S; Yuce A
    Eur J Med Genet; 2021 Nov; 64(11):104339. PubMed ID: 34500086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyneuropathy in Gaucher disease type 1 and 3 - a descriptive case series.
    Andréasson M; Solders G; Björkvall CK; Machaczka M; Svenningsson P
    Sci Rep; 2019 Oct; 9(1):15358. PubMed ID: 31653957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral delivery of a microRNA to Gba to the mouse central nervous system models neuronopathic Gaucher disease.
    Jackson KL; Viel C; Clarke J; Bu J; Chan M; Wang B; Shihabuddin LS; Sardi SP
    Neurobiol Dis; 2019 Oct; 130():104513. PubMed ID: 31233883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.
    McNeill A; Magalhaes J; Shen C; Chau KY; Hughes D; Mehta A; Foltynie T; Cooper JM; Abramov AY; Gegg M; Schapira AH
    Brain; 2014 May; 137(Pt 5):1481-95. PubMed ID: 24574503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease.
    Horowitz M; Braunstein H; Zimran A; Revel-Vilk S; Goker-Alpan O
    Adv Drug Deliv Rev; 2022 Aug; 187():114402. PubMed ID: 35764179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation.
    Zhang CK; Stein PB; Liu J; Wang Z; Yang R; Cho JH; Gregersen PK; Aerts JM; Zhao H; Pastores GM; Mistry PK
    Am J Hematol; 2012 Apr; 87(4):377-83. PubMed ID: 22388998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of sibling pairs with gaucher disease discordant for parkinsonism.
    Lopez G; Steward A; Ryan E; Groden C; Wiggs E; Segalà L; Monestime GM; Tayebi N; Sidransky E
    Mov Disord; 2020 Feb; 35(2):359-365. PubMed ID: 31785030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry.
    Rosenbloom B; Balwani M; Bronstein JM; Kolodny E; Sathe S; Gwosdow AR; Taylor JS; Cole JA; Zimran A; Weinreb NJ
    Blood Cells Mol Dis; 2011 Jan; 46(1):95-102. PubMed ID: 21067946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel mutation causing type 1 Gaucher disease found in a Japanese patient with gastric cancer: A case report.
    Hosoba S; Kito K; Teramoto Y; Adachi K; Nakanishi R; Asai A; Iwasa M; Nishimura R; Moritani S; Kawahara M; Minamiguchi H; Nanba E; Kushima R; Andoh A
    Medicine (Baltimore); 2018 Jul; 97(27):e11361. PubMed ID: 29979419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the diagnostic utility of the Gaucher Earlier Diagnosis Consensus (GED-C) scoring system using real-world data.
    Revel-Vilk S; Shalev V; Gill A; Paltiel O; Manor O; Tenenbaum A; Azani L; Chodick G
    Orphanet J Rare Dis; 2024 Feb; 19(1):71. PubMed ID: 38365689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Audiometric abnormalities in children with Gaucher disease type 3.
    Bamiou DE; Campbell P; Liasis A; Page J; Sirimanna T; Boyd S; Vellodi A; Harris C
    Neuropediatrics; 2001 Jun; 32(3):136-41. PubMed ID: 11521209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization.
    Saunders-Pullman R; Hagenah J; Dhawan V; Stanley K; Pastores G; Sathe S; Tagliati M; Condefer K; Palmese C; Brüggemann N; Klein C; Roe A; Kornreich R; Ozelius L; Bressman S
    Mov Disord; 2010 Jul; 25(10):1364-72. PubMed ID: 20629126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.
    Beavan M; McNeill A; Proukakis C; Hughes DA; Mehta A; Schapira AH
    JAMA Neurol; 2015 Feb; 72(2):201-8. PubMed ID: 25506732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gaucher disease type 3c: New patients with unique presentations and review of the literature.
    Kurolap A; Del Toro M; Spiegel R; Gutstein A; Shafir G; Cohen IJ; Barrabés JA; Feldman HB
    Mol Genet Metab; 2019 Jun; 127(2):138-146. PubMed ID: 31130326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease.
    Weill Y; Zimran A; Zadok D; Wasser LM; Revel-Vilk S; Hanhart J; Dinur T; Arkadir D; Becker-Cohen M
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled attenuation parameter and liver stiffness measurements using transient elastography by FibroScan in Gaucher disease.
    Lipiński P; Szymańska-Rożek P; Socha P; Tylki-Szymańska A
    Mol Genet Metab; 2020 Feb; 129(2):125-131. PubMed ID: 31704237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatosensory evoked potentials as a marker of disease burden in type 3 Gaucher disease.
    Garvey MA; Toro C; Goldstein S; Altarescu G; Wiggs EA; Hallett M; Schiffmann R
    Neurology; 2001 Feb; 56(3):391-4. PubMed ID: 11171908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A characterization of Gaucher iPS-derived astrocytes: Potential implications for Parkinson's disease.
    Aflaki E; Stubblefield BK; McGlinchey RP; McMahon B; Ory DS; Sidransky E
    Neurobiol Dis; 2020 Feb; 134():104647. PubMed ID: 31669751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.